血液透析治疗糖尿病肾病终末期疗效和并发症分析  

Treatment of diabetic nephropathy by hemodialysis and the analysis of complications

作　　者：郑宇 滑晓莉 

机构地区：[1]昌吉市人民医院,新疆昌吉831100

出　　处：《当代医学》2018年第6期15-17,共3页Contemporary Medicine

摘　　要：目的分析血液透析前后糖尿病肾病终末期患者临床指标变化,为临床治疗提高参考。方法选取患有糖尿病肾病终末期、慢性肾小球肾炎患者为研究对象,糖尿病患者依照是否使用血液透析分为A组(42例)和B组(36例),慢性肾小球肾炎患者为C组(40例),A组和C组患者实施血液透析治疗,B组患者采取非透析指标,分析治疗效果。结果糖尿病肾病终末期血液透析后血糖和肾功能指标得到改善,治疗中并发症较多,A组患者并发症发生率显著高于其他两组(P<0.05)。结论血液透析治疗终末期糖尿病肾病疗效明确,并发症较多,建议实施个性化胰岛素,减少血糖波动。Objective To analyze the clinical index changes of patients with diabetic nephropathy before and after hemodialysis,and to improve the reference for clinical treatment.Methods Select end-stage diabetic nephropathy,chronic glomerulonephritis patients as the research object,according to whether or not to use hemodialysis patients with diabetes were divided into group A(42 cases) and group B(36 cases),chronic glomerulonephritis patients in group C(40 cases),A and C groups of patients with hemodialysis therapy,group B patients take the dialysis index,analysis of therapeutic effect.Results Diabetic nephropathy end-stage blood glucose and renal function after hemodialysis indicators improved,treatment of complications is more,A group had A significantly higher incidence of complications in patients with other two groups(P<0.05).Conclusion Hemodialysis is effective in the treatment of diabetic nephropathy and has more complications.It is suggested to implement personalized insulin and reduce blood glucose fluctuation.

关 键 词：终末期糖尿病肾病 血糖 血液透析 并发症 

分 类 号：R587.2[医药卫生—内分泌]